| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/19/2007 | US20070167491 N-[2-(5-chloro-2-pyridinyl)propyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, used for the control of phytopathogenic fungi of plants; pesticides |
| 07/19/2007 | US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 07/19/2007 | US20070167473 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 07/19/2007 | US20070167472 2-Methoxy-ethanesulfamic acid [6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-5-(2-chloro-5-methoxy-phenoxy)-pyrimidin-4-yl]-amide; vasoconstrictor, mediator of cardiac, renal, endocrine functions; neurotransmitter release, activation of inflammatory cells, fibrosis, cell proliferation and differentiation |
| 07/19/2007 | US20070167471 Substituted quinazoline compounds useful as p38 kinase inhibitors |
| 07/19/2007 | US20070167470 Spiro compounds and methods of use |
| 07/19/2007 | US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 07/19/2007 | US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder |
| 07/19/2007 | US20070167456 Mercaptoimidazoles as ccr2 receptor antagonists |
| 07/19/2007 | US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES |
| 07/19/2007 | US20070167449 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 07/19/2007 | US20070167448 Derivatives of sulphonamides, their preparation and use as medicaments |
| 07/19/2007 | US20070167447 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof |
| 07/19/2007 | US20070167443 Substituted quinolones and methods of use |
| 07/19/2007 | US20070167440 Novel pyrrolidine compound and a process for preparing the same |
| 07/19/2007 | US20070167439 N4-(1-tert-Butoxycarbonylazetidin-3-yl)-5-fluoro-N2-(4-morpholinophenyl)-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE ("Fc epsilon RI") and IgG ("Fc gamma RI") antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis |
| 07/19/2007 | US20070167423 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 07/19/2007 | US20070167421 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
| 07/19/2007 | US20070167413 Novel heterocycles |
| 07/19/2007 | US20070167406 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 07/19/2007 | DE102005057912A1 In 3-Position heterocyclisch substituierte Pyrrolidin(thi)one In the 3-position hetero-substituted pyrrolidine (thi) ones |
| 07/19/2007 | CA2635997A1 Morpholino pyrimidine derivatives and their use in therapy |
| 07/19/2007 | CA2635916A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 07/19/2007 | CA2635360A1 Amino acid derivatives of indolinone based protein kinase inhibitors |
| 07/19/2007 | CA2635083A1 Oxazolidinone derivatives as cetp inhibitors |
| 07/18/2007 | EP1808433A1 Compound containing fused ring and organic electroluminescent element employing the same |
| 07/18/2007 | EP1807418A2 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 07/18/2007 | EP1807417A2 Pyrazolylmethyl heteroaryl derivatives |
| 07/18/2007 | EP1807413A1 Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 07/18/2007 | EP1807412A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 07/18/2007 | EP1807399A2 Indole and benzimidazole derivatives |
| 07/18/2007 | EP1807085A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 07/18/2007 | EP1807082A2 Factor xa compounds |
| 07/18/2007 | EP1807077A2 Inhibitors of c-fms kinase |
| 07/18/2007 | EP1807072A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/18/2007 | EP1725239B1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy |
| 07/18/2007 | EP1711184B1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/18/2007 | EP1565436A4 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/18/2007 | EP1558598B1 Triazole compounds for the treatment of dysmenorrhoea |
| 07/18/2007 | EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 07/18/2007 | EP1458711B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 07/18/2007 | EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 07/18/2007 | CN1326851C Ligustrazine alkyl piperazine derivative, and its preparing method and medicinal composition and use |
| 07/18/2007 | CN1326850C Tricyclic farnesyl protein transferase inhibitors |
| 07/18/2007 | CN1326849C Hexahydro-phthalmide compound, its preparation and use thereof |
| 07/18/2007 | CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity |
| 07/18/2007 | CN1326838C Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 07/18/2007 | CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/18/2007 | CN101001845A Substituted quinazolones as anti-cancer agents. |
| 07/18/2007 | CN101001844A Mercaptoimidazoles as CCR2 receptor antagonists |
| 07/18/2007 | CN101001840A Therapeutic compounds: pyridine as scaffold |
| 07/18/2007 | CN101001625A Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 07/18/2007 | CN100999518A Voriconazole derivate and preparation process thereof |
| 07/18/2007 | CN100999501A Process for the preparation of 2-methyl piperazine derivatives |
| 07/17/2007 | US7244847 Bactericides |
| 07/17/2007 | US7244747 For therapy of epilepsy, epileptogenesis, seizure disorders, convulsions, dyskinesia and neuropathic pain in a mammal |
| 07/17/2007 | US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/17/2007 | US7244738 Urogenital disorders; sexual diosrders; benign prostatic hyperplasia; analgesics |
| 07/17/2007 | US7244736 useful in the treatment of cancer; taxane-like effects on microtubule polymerization that are not substrates of P-glycoprotein |
| 07/17/2007 | US7244735 useful for treating cancer, neurological disorders, autoimmune disorders, and other diseases that are alleviated by protein kinase inhibitors |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244724 Pyrrolobenzodiazepines |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/12/2007 | WO2007079199A2 Substituted bis-amide metalloprotease inhibitors |
| 07/12/2007 | WO2007078839A2 Compounds, compositions and methods |
| 07/12/2007 | WO2007077961A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | WO2007077435A1 Pharmaceutical compounds |
| 07/12/2007 | WO2007077247A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | WO2007077201A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | WO2007077186A1 Pdf inhibitors |
| 07/12/2007 | WO2007076709A1 Tri-substituted 1h-imidazolyl compounds, preparation methods, pharmaceutical compositions and pharmaceutical uses thereof |
| 07/12/2007 | WO2007059257A8 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 07/12/2007 | WO2007052301A3 Process for the preparation of irbesartan |
| 07/12/2007 | WO2007052123A3 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 07/12/2007 | WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof |
| 07/12/2007 | WO2007029078A3 Succinimide and glutarimide derivatives as adrenergic receptor antagonists |
| 07/12/2007 | US20070161794 Slurrying aripiprazole in a solvent (acetone), heating and isolating anhydrous aripiprazole Form II from the slurry |
| 07/12/2007 | US20070161793 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative |
| 07/12/2007 | US20070161689 Indoles having anti-diabetic activity |
| 07/12/2007 | US20070161682 Using 2-(((-4-x, 3,5-dimethylpyridin-2-yl)methylthio)5-methoxy-1H-benzimidazole where x is a leaving group; oxidation using titanium complex catalyst and base |
| 07/12/2007 | US20070161680 {1-Methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)-amine; inhibitors of kinase/ Raf kinase activity associated with tumorigenesis, serine/threonine kinase or receptor tyrosine kinase; cancer; tumors; inhibitMAPK signaling pathway |
| 07/12/2007 | US20070161676 {1-[4-(3-Pyrrolidin-1-ylpropoxy)phenyl]-1H-indol-2-yl}methanol; inflammation, migraine, motion sickness, pain, Parkinson's Disease, epilepsy, cardiovascular disease (i.e. hyper or hypotension, acute myocardial infarction), gastrointestinal disorders; cognitive disorders |
| 07/12/2007 | US20070161671 7-Azaindoles and the use thereof as therapeutic agents |
| 07/12/2007 | US20070161669 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 07/12/2007 | US20070161664 Therapeutic compounds |
| 07/12/2007 | US20070161651 Tie-2 modulators and methods of use |
| 07/12/2007 | US20070161649 e.g. 6-Methoxy-(4-benzylpiperidinyl)-indole-5-carboxamide-3-glyoxalic acid; antiinflammatory, antiproliferative agent; neurodegenerative diseases |
| 07/12/2007 | US20070161648 Substituted dihydro-isoindolones useful in treating kinase disorders |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161644 Erastin analogs and uses thereof |
| 07/12/2007 | US20070161642 Drug for inhibiting vascular intimal hyperplasia |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161637 Substituted pyridin-2-ylamine analogues |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161634 Compounds as CCR5 antagonists |
| 07/12/2007 | US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/12/2007 | US20070161628 Phosphodiesterase inhibitors |